3 unknown, 1 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 3, Completed 1 |
Follow idebenone: new trials by email Literature Review of idebenone trials Research Report on idebenone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy idebenone 30 mg for 14 days, idebenone 30 mg for 3 months - Post Stroke Epilepsy | Phase 4 | Unknown | Xiangya Hospital of Central South University | 2700 | 2023-07-05 | 2023-08-14 |
| Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients Idebenone+ placebo, Idebenone, Placebo - Migraine | Phase 4 | Unknown | Beijing Tiantan Hospital | 900 | 2022-05-09 | 2022-06-23 |
| Idebenone Treatment of Early Parkinson's Diseasesymptoms Idebenone/placebo - Oxidative Stress is an Important Cause of Parkinson's Disease | Phase 4 | Unknown | Second Affiliated Hospital of Soochow University | 180 | 2019-01-01 | 2018-11-01 |
| Study to Assess the Efficacy and Safety of Raxone in LHON Patients Idebenone - Leber's Hereditary Optic Neuropathy (LHON) | Phase 4 | Completed | Santhera Pharmaceuticals | 199 | 2016-05-01 | 2023-04-21 |
Migraine Disorders (1) · Mitochondrial Diseases (1) · Optic Atrophy, Hereditary, Leber (1)
Beijing Tiantan Hospital (1) · Santhera Pharmaceuticals (1) · Second Affiliated Hospital of Soochow University (1) · Xiangya Hospital of Central South University (1)
China (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Germany (1) · Italy (1) · Poland (1) · Portugal (1) · Spain (1) · United Kingdom (1) · United States (1)